BISSARO, MAICOL
 Distribuzione geografica
Continente #
NA - Nord America 998
AS - Asia 115
EU - Europa 100
SA - Sud America 3
Totale 1.216
Nazione #
US - Stati Uniti d'America 997
SG - Singapore 64
CN - Cina 48
IT - Italia 30
FR - Francia 21
FI - Finlandia 15
SE - Svezia 12
IE - Irlanda 7
DE - Germania 4
GB - Regno Unito 4
AR - Argentina 3
AT - Austria 3
IN - India 2
NL - Olanda 2
BE - Belgio 1
GT - Guatemala 1
IR - Iran 1
UA - Ucraina 1
Totale 1.216
Città #
Fairfield 167
Ashburn 100
Chandler 93
Woodbridge 75
Houston 71
Seattle 62
Cambridge 61
Singapore 57
Wilmington 44
Santa Clara 35
San Diego 28
Ann Arbor 23
Boardman 22
Medford 18
Princeton 18
Helsinki 15
Des Moines 11
Roxbury 11
Padova 9
Beijing 7
Dublin 7
Nanjing 5
Ogden 3
Chicago 2
Cividale del Friuli 2
Columbus 2
Cordoba 2
Dallas 2
Jinan 2
Los Angeles 2
Ningbo 2
Acton 1
Bologna 1
Borås 1
Brentford 1
Brescia 1
Changsha 1
Clifton 1
Council Bluffs 1
Florence 1
Gmunden 1
Groningen 1
Guangzhou 1
Guatemala City 1
Haikou 1
Hangzhou 1
Innsbruck 1
Kharkiv 1
Lanzhou 1
London 1
Mahbubnagar 1
Milan 1
Moron 1
Munich 1
Nanchang 1
Norwalk 1
Nürnberg 1
Perugia 1
Pune 1
Redmond 1
Sarcelles 1
Selvazzano Dentro 1
Zhengzhou 1
Totale 990
Nome #
Targeting Protein Kinase CK1δ with Riluzole: Could It Be One of the Possible Missing Bricks to Interpret Its Effect in the Treatment of ALS from a Molecular Point of View? 110
Can We Still Trust Docking Results? An Extension of the Applicability of DockBench on PDBbind Database 99
A Triazolotriazine-Based Dual GSK-3β/CK-1δ Ligand as a Potential Neuroprotective Agent Presenting Two Different Mechanisms of Enzymatic Inhibition 95
Revisiting the Allosteric Regulation of Sodium Cation on the Binding of Adenosine at the Human A2A Adenosine Receptor: Insights from Supervised Molecular Dynamics (SuMD) Simulations 92
Deciphering the Molecular Recognition Mechanism of Multidrug Resistance Staphylococcus aureus NorA Efflux Pump Using a Supervised Molecular Dynamics Approach 83
Scaffold Repurposing of in-House Chemical Library toward the Identification of New Casein Kinase 1 δinhibitors 76
The rise of molecular simulations in fragment-based drug design (FBDD): an overview 76
On The Mechanism Of Tumor Cell Entry Of Aloe-Emodin, A Natural Compound Endowed With Anticancer Activity 70
HT-SuMD: making molecular dynamics simulations suitable for fragment-based screening. A comparative study with NMR 68
Rethinking to riluzole mechanism of action: the molecular link among protein kinase CK1δ activity, TDP-43 phosphorylation, and amyotrophic lateral sclerosis pharmacological treatment 61
A Computational Workflow for the Identification of Novel Fragments Acting as Inhibitors of the Activity of Protein Kinase CK1 delta 59
Exploring the RNA-Recognition Mechanism Using Supervised Molecular Dynamics (SuMD) Simulations: Toward a Rational Design for Ribonucleic-Targeting Molecules? 59
New insights into key determinants for adenosine 1 receptor antagonists selectivity using supervised molecular dynamics simulations 55
Inspecting the Mechanism of Fragment Hits Binding on SARS‐CoV‐2 M pro by Using Supervised Molecular Dynamics (SuMD) Simulations 49
Developing novel classes of protein kinase CK1δ inhibitors by fusing [1,2,4]triazole with different bicyclic heteroaromatic systems 46
Comparing fragment binding posesprediction using HSP90 as a key study: When bound water makes the difference 42
Shedding Light on the Molecular Recognition of Sub-Kilodalton Macrocyclic Peptides on Thrombin by Supervised Molecular Dynamics 41
Targeting the coronavirus SARS-CoV-2: computational insights into the mechanism of action of the protease inhibitors lopinavir, ritonavir and nelfinavir 39
Computational Strategies to Identify New Drug Candidates against Neuroinflammation 22
Totale 1.242
Categoria #
all - tutte 5.995
article - articoli 5.995
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.990


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020153 0 0 0 0 21 10 18 22 38 21 15 8
2020/2021259 11 12 53 13 12 7 0 30 38 22 19 42
2021/2022281 8 10 20 23 11 19 21 39 52 14 10 54
2022/2023193 37 5 2 15 36 26 4 24 24 10 7 3
2023/2024139 6 30 17 8 14 19 6 5 7 4 8 15
2024/2025176 5 82 24 25 40 0 0 0 0 0 0 0
Totale 1.242